Baseline TP53 mutations in adults with SCD developing myeloid malignancy following hematopoietic cell transplantation

There is a Blood Commentary on this article in this issue.

Saved in:

Bibliographic Details
Published in	Blood Vol. 135; no. 14; pp. 1185 - 1188
Main Authors	Ghannam, Jack Y., Xu, Xin, Maric, Irina, Dillon, Laura, Li, Yuesheng, Hsieh, Matthew M., Hourigan, Christopher S., Fitzhugh, Courtney D.
Format	Journal Article
Language	English
Published	United States Elsevier Inc 02.04.2020 American Society of Hematology
Subjects	Adult Anemia, Sickle Cell - complications Anemia, Sickle Cell - genetics Anemia, Sickle Cell - therapy Hematopoietic Stem Cell Transplantation - adverse effects Humans Letter to Leukemia, Myeloid, Acute - etiology Leukemia, Myeloid, Acute - genetics Myelodysplastic Syndromes - etiology Myelodysplastic Syndromes - genetics Point Mutation Tumor Suppressor Protein p53 - genetics
Online Access	Get full text
ISSN	0006-4971 1528-0020 1528-0020
DOI	10.1182/blood.2019004001

More Information
Summary:	There is a Blood Commentary on this article in this issue.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 ObjectType-Correspondence-3 content type line 23 C.S.H. and C.D.F. contributed equally to this study. J.Y.G. and X.X. contributed equally to this study.
ISSN:	0006-4971 1528-0020 1528-0020
DOI:	10.1182/blood.2019004001